4//SEC Filing
Stankovic Srdjan R. 4
Accession 0001209191-22-013275
CIK 0001070494other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 5:41 PM ET
Size
8.8 KB
Accession
0001209191-22-013275
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2022-02-23$23.80/sh−1,501$35,724→ 48,437 total - Exercise/Conversion
Restricted Stock Units
2022-02-23+4,919→ 14,758 total→ Common Stock (4,919 underlying) - Exercise/Conversion
Common Stock
2022-02-23+4,919→ 49,938 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The restricted stock units vest in four equal annual installments beginning February 23 2022.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeother
Related Parties
1- filerCIK 0001432545
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 5:41 PM ET
- Size
- 8.8 KB